Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
23
CABA Quote, Financials, Valuation and Earnings
Last price:
$1.69
Seasonality move
:
-7.7%
Day range:
$1.64 - $1.72
52-week range:
$0.99 - $7.88
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
0.71x
Volume:
732.5K
Avg. volume:
2.5M
1-year change:
-78.5%
Market cap:
$85.8M
Revenue:
--
EPS (TTM):
-$2.54
Earnings Data
Next earnings date for CABA
Aug 08
2025
Most recent earnings per share
-$0.71
Missed by $0.05
(May 15/2025)
Consensus Estimate
-$0.66
(May 15/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
CABA Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $833.3K | -- | -- | -$0.67 | -- |
| 08/08/2025 | Q2 | $4.2M | -- | -- | -$0.61 | -- |
| 05/15/2025 | Q1 | -- | -- | -$0.71 | -$0.66 | -$0.05 |
| 03/31/2025 | Q4 | -- | -- | -$0.65 | -$0.63 | -$0.02 |
| 11/14/2024 | Q3 | -- | -- | -$0.62 | -$0.61 | -$0.01 |
| 08/08/2024 | Q2 | -- | -- | -$0.56 | -$0.57 | $0.01 |
| 05/15/2024 | Q1 | -- | -- | -$0.51 | -$0.48 | -$0.03 |
| 03/21/2024 | Q4 | -- | -- | -$0.47 | -$0.39 | -$0.08 |
| 11/09/2023 | Q3 | -- | -- | -$0.37 | -$0.42 | $0.05 |
| 08/10/2023 | Q2 | -- | -- | -$0.37 | -$0.42 | $0.05 |
| 05/11/2023 | Q1 | -- | -- | -$0.45 | -$0.47 | $0.02 |
| 03/16/2023 | Q4 | -- | -- | -$0.52 | -$0.44 | -$0.08 |
| 11/10/2022 | Q3 | -- | -- | -$0.39 | -$0.47 | $0.08 |
| 08/11/2022 | Q2 | -- | -- | -$0.45 | -$0.50 | $0.05 |
| 05/12/2022 | Q1 | -- | -- | -$0.45 | -$0.53 | $0.08 |
| 03/17/2022 | Q4 | -- | -- | -$0.49 | -$0.52 | $0.03 |
| 11/01/2021 | Q3 | -- | -- | -$0.45 | -$0.48 | $0.03 |
| 08/05/2021 | Q2 | -- | -- | -$0.45 | -$0.41 | -$0.04 |
| 05/03/2021 | Q1 | -- | -- | -$0.41 | -$0.38 | -$0.03 |
| 03/16/2021 | Q4 | -- | -- | -$0.40 | -$0.37 | -$0.03 |
| 11/10/2020 | Q3 | -- | -- | -$0.36 | -- | -- |
| 08/06/2020 | Q2 | -- | -- | -$0.35 | -- | -- |
| 05/12/2020 | Q1 | -- | -- | -$0.33 | -- | -- |
| 03/30/2020 | Q4 | -- | -- | -$0.33 | -- | -- |
| 09/30/2019 | Q3 | -- | -- | -$0.21 | -- | -- |
| 06/30/2019 | Q2 | -- | -- | -$0.23 | -- | -- |
| 03/31/2019 | Q1 | -- | -- | -$0.61 | -- | -- |
| 12/31/2018 | Q4 | -- | -- | -$0.13 | -- | -- |
| 09/30/2018 | Q3 | -- | -- | -$0.64 | -- | -- |
Cabaletta Bio Earnings Questions
-
How Much did Cabaletta Bio Generate in Revenue Last Quarter?
Cabaletta Bio reported -- worth of top line sales in its most recent quarter.
-
Did Cabaletta Bio Beat Earnings Last Quarter?
Cabaletta Bio announced earnings per share of -$0.71 which represents a miss of analyst forecast a -$0.66 per share.
-
Is Cabaletta Bio Profitable?
Cabaletta Bio reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Cabaletta Bio EPS Next Year?
Cabaletta Bio's earnings are forecast to decrease from -$2.34 per share to -$2.21 per share next year representing a decrease of -0.91%.
-
When is Cabaletta Bio's Earnings Date?
Cabaletta Bio's next earnings date is August 8, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
